Report Detail
Global Ivacaftor API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
- RnM4512498 |
- 16 February, 2023 |
- Global |
- 99 Pages |
- GIR (Global Info Research) |
- Chemical & Material
Ivacaftor is a drug used to treat cystic fibrosis in people with certain mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene (primarily the G551D mutation), who account for 4–5% cases of cystic fibrosis.
According to our (Global Info Research) latest study, the global Ivacaftor API market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Ivacaftor API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Ivacaftor API market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2018-2029
Global Ivacaftor API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2018-2029
Global Ivacaftor API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2018-2029
Global Ivacaftor API market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/MT), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ivacaftor API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ivacaftor API market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Tecoland, FCDA, Jigs chemical, Pharmaffiliates and Struchem, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Ivacaftor API market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Market segment by Application
Research
Pharmaceutical
Major players covered
Tecoland
FCDA
Jigs chemical
Pharmaffiliates
Struchem
AlchemyPharm
Shijiazhuang Dingmin Pharmaceutical Sciences
Synbest
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ivacaftor API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ivacaftor API, with price, sales, revenue and global market share of Ivacaftor API from 2018 to 2023.
Chapter 3, the Ivacaftor API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ivacaftor API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Ivacaftor API market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ivacaftor API.
Chapter 14 and 15, to describe Ivacaftor API sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Ivacaftor API
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Ivacaftor API Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Min Purity Less Than 98%
- 1.3.3 Min Purity 98%-99%
- 1.3.4 Min Purity More Than 99%
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Ivacaftor API Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Research
- 1.4.3 Pharmaceutical
- 1.5 Global Ivacaftor API Market Size & Forecast
- 1.5.1 Global Ivacaftor API Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global Ivacaftor API Sales Quantity (2018-2029)
- 1.5.3 Global Ivacaftor API Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 Tecoland
- 2.1.1 Tecoland Details
- 2.1.2 Tecoland Major Business
- 2.1.3 Tecoland Ivacaftor API Product and Services
- 2.1.4 Tecoland Ivacaftor API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Tecoland Recent Developments/Updates
- 2.2 FCDA
- 2.2.1 FCDA Details
- 2.2.2 FCDA Major Business
- 2.2.3 FCDA Ivacaftor API Product and Services
- 2.2.4 FCDA Ivacaftor API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 FCDA Recent Developments/Updates
- 2.3 Jigs chemical
- 2.3.1 Jigs chemical Details
- 2.3.2 Jigs chemical Major Business
- 2.3.3 Jigs chemical Ivacaftor API Product and Services
- 2.3.4 Jigs chemical Ivacaftor API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Jigs chemical Recent Developments/Updates
- 2.4 Pharmaffiliates
- 2.4.1 Pharmaffiliates Details
- 2.4.2 Pharmaffiliates Major Business
- 2.4.3 Pharmaffiliates Ivacaftor API Product and Services
- 2.4.4 Pharmaffiliates Ivacaftor API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Pharmaffiliates Recent Developments/Updates
- 2.5 Struchem
- 2.5.1 Struchem Details
- 2.5.2 Struchem Major Business
- 2.5.3 Struchem Ivacaftor API Product and Services
- 2.5.4 Struchem Ivacaftor API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Struchem Recent Developments/Updates
- 2.6 AlchemyPharm
- 2.6.1 AlchemyPharm Details
- 2.6.2 AlchemyPharm Major Business
- 2.6.3 AlchemyPharm Ivacaftor API Product and Services
- 2.6.4 AlchemyPharm Ivacaftor API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 AlchemyPharm Recent Developments/Updates
- 2.7 Shijiazhuang Dingmin Pharmaceutical Sciences
- 2.7.1 Shijiazhuang Dingmin Pharmaceutical Sciences Details
- 2.7.2 Shijiazhuang Dingmin Pharmaceutical Sciences Major Business
- 2.7.3 Shijiazhuang Dingmin Pharmaceutical Sciences Ivacaftor API Product and Services
- 2.7.4 Shijiazhuang Dingmin Pharmaceutical Sciences Ivacaftor API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Shijiazhuang Dingmin Pharmaceutical Sciences Recent Developments/Updates
- 2.8 Synbest
- 2.8.1 Synbest Details
- 2.8.2 Synbest Major Business
- 2.8.3 Synbest Ivacaftor API Product and Services
- 2.8.4 Synbest Ivacaftor API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Synbest Recent Developments/Updates
3 Competitive Environment: Ivacaftor API by Manufacturer
- 3.1 Global Ivacaftor API Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global Ivacaftor API Revenue by Manufacturer (2018-2023)
- 3.3 Global Ivacaftor API Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of Ivacaftor API by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 Ivacaftor API Manufacturer Market Share in 2022
- 3.4.2 Top 6 Ivacaftor API Manufacturer Market Share in 2022
- 3.5 Ivacaftor API Market: Overall Company Footprint Analysis
- 3.5.1 Ivacaftor API Market: Region Footprint
- 3.5.2 Ivacaftor API Market: Company Product Type Footprint
- 3.5.3 Ivacaftor API Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Ivacaftor API Market Size by Region
- 4.1.1 Global Ivacaftor API Sales Quantity by Region (2018-2029)
- 4.1.2 Global Ivacaftor API Consumption Value by Region (2018-2029)
- 4.1.3 Global Ivacaftor API Average Price by Region (2018-2029)
- 4.2 North America Ivacaftor API Consumption Value (2018-2029)
- 4.3 Europe Ivacaftor API Consumption Value (2018-2029)
- 4.4 Asia-Pacific Ivacaftor API Consumption Value (2018-2029)
- 4.5 South America Ivacaftor API Consumption Value (2018-2029)
- 4.6 Middle East and Africa Ivacaftor API Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global Ivacaftor API Sales Quantity by Type (2018-2029)
- 5.2 Global Ivacaftor API Consumption Value by Type (2018-2029)
- 5.3 Global Ivacaftor API Average Price by Type (2018-2029)
6 Market Segment by Application
- 6.1 Global Ivacaftor API Sales Quantity by Application (2018-2029)
- 6.2 Global Ivacaftor API Consumption Value by Application (2018-2029)
- 6.3 Global Ivacaftor API Average Price by Application (2018-2029)
7 North America
- 7.1 North America Ivacaftor API Sales Quantity by Type (2018-2029)
- 7.2 North America Ivacaftor API Sales Quantity by Application (2018-2029)
- 7.3 North America Ivacaftor API Market Size by Country
- 7.3.1 North America Ivacaftor API Sales Quantity by Country (2018-2029)
- 7.3.2 North America Ivacaftor API Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe Ivacaftor API Sales Quantity by Type (2018-2029)
- 8.2 Europe Ivacaftor API Sales Quantity by Application (2018-2029)
- 8.3 Europe Ivacaftor API Market Size by Country
- 8.3.1 Europe Ivacaftor API Sales Quantity by Country (2018-2029)
- 8.3.2 Europe Ivacaftor API Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific Ivacaftor API Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific Ivacaftor API Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific Ivacaftor API Market Size by Region
- 9.3.1 Asia-Pacific Ivacaftor API Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific Ivacaftor API Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America Ivacaftor API Sales Quantity by Type (2018-2029)
- 10.2 South America Ivacaftor API Sales Quantity by Application (2018-2029)
- 10.3 South America Ivacaftor API Market Size by Country
- 10.3.1 South America Ivacaftor API Sales Quantity by Country (2018-2029)
- 10.3.2 South America Ivacaftor API Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa Ivacaftor API Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa Ivacaftor API Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa Ivacaftor API Market Size by Country
- 11.3.1 Middle East & Africa Ivacaftor API Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa Ivacaftor API Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 Ivacaftor API Market Drivers
- 12.2 Ivacaftor API Market Restraints
- 12.3 Ivacaftor API Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 12.5 Influence of COVID-19 and Russia-Ukraine War
- 12.5.1 Influence of COVID-19
- 12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
- 13.1 Raw Material of Ivacaftor API and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Ivacaftor API
- 13.3 Ivacaftor API Production Process
- 13.4 Ivacaftor API Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Ivacaftor API Typical Distributors
- 14.3 Ivacaftor API Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Ivacaftor API. Industry analysis & Market Report on Ivacaftor API is a syndicated market report, published as Global Ivacaftor API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Ivacaftor API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
